Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI) [Phase 3]
Open-label Phase 3 assessment of the Albuterol Spiromax dry powder inhaler in patients with asthma and chronic obstructive pulmonary disease…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma [Phase 2]
Phase 2 dose-ranging trial assessing albuterol with hydrofluoroalkane in adolescents and adults with persistent asthma; study completed with…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: In Vitro Assessment of a Breath-synchronized Vibrating Mesh Nebulizer During Non Invasive Ventilation [NA]
A completed study evaluating the in vitro performance of a breath-synchronized vibrating mesh nebulizer during noninvasive ventilation.
-
FDA approval · 2015-06-03FDA Approved: BUDESONIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for budesonide submitted by Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Efficacy Study of SYN006 HFA MDI in Asthma Patients [Phase 2]
This clinical trial update reports the completion of a Phase 2 efficacy study of SYN006 HFA MDI in asthma patients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Bioavailability Study of SYN006, Pulmicort pMDI and Meptin Air in Healthy Adult. [Phase 1]
Phase 1 bioavailability study evaluating SYN006 with Pulmicort pMDI and Meptin Air in healthy adults has completed.
-
CLINICAL_TRIALS research · 2015-06-03Clinical Trial Update: Multiple-dose Pharmacokinetics Study of "SYN006 HFA MDI" Administered Orally to Healthy Volunteers [Phase 1]
A Phase 1 pharmacokinetics study of SYN006 HFA MDI given orally to healthy volunteers has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-02Clinical Trial Update: Do Bonding Disruptions Occur More Often in Children With Asthma Than in Non-asthmatic Populations?
A completed clinical trial evaluated whether bonding disruptions occur more often in children with asthma than in non-asthmatic children.
-
CLINICAL_TRIALS trial_result · 2015-06-01Clinical Trial Update: Plasma Levels of MK0633 in Children Ages 6-12 (0633-023) [Phase 1]
This completed Phase 1 trial reports the plasma PK levels of MK0633 in children aged 6-12 with asthma.
-
CLINICAL_TRIALS trial_result · 2015-06-01Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Plasma Concentration Profiles of MK0633 in Asthmatic Children Aged 12 to Less Than 16 Years (0633-019) [Phase 1]
Phase 1 safety and tolerability trial of MK0633 in asthmatic children aged 12 to under 16, including plasma concentration profiling; the stu…
-
CLINICAL_TRIALS research · 2015-06-01Clinical Trial Update: Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs With and Without Airflow Obstruction [NA]
This clinical trial update describes evaluating pulmonary arteriovenous malformations with and without airflow obstruction using cardiopulmo…
-
CLINICAL_TRIALS withdrawal · 2015-06-01Clinical Trial Update: Bronchoscopy Study for Severe Asthma
A bronchoscopy study for severe asthma sponsored by the University of Pennsylvania has been withdrawn. The trial identifier is NCT01745809.
-
CLINICAL_TRIALS trial_result · 2015-06-01Clinical Trial Update: Asthma, Missed Immunizations, and Vitamin D Deficiency in Atopic Dermatitis
The trial examining asthma, missed immunizations, and vitamin D deficiency in atopic dermatitis was terminated.
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Study to Assess the Effect of the NEXThaler® Device (DPI - Dry Powder Inhaler) on the Central and Peripheral Airway Dimensions in Asthmatic Patients [Phase 2]
Phase 2 study assessing the impact of the NEXThaler dry powder inhaler on central and peripheral airway dimensions in patients with asthma; …
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Breathing and Relaxation Exercises for Asthma: a Randomised Controlled Trial [NA]
This randomized controlled trial evaluated whether breathing and relaxation exercises benefit people with asthma. The study has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Understanding and Appraising the New Medicine Service in England [NA]
Completed clinical trial evaluating the understanding and appraisal of the New Medicine Service in England.
-
CLINICAL_TRIALS research · 2015-05-28Clinical Trial Update: Measurement of Natriuretic Hormone Peptides in Exacerbation of Asthma
A completed clinical study that investigates natriuretic hormone peptide levels during asthma exacerbations to explore biomarkers.
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: A Study of MK0359 in Patients With Chronic Asthma (0359-013) [Phase 2]
A Phase 2 clinical trial evaluating MK0359 in patients with chronic asthma has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-25Clinical Trial Update: Evaluation of Metabolic Profile of OC000459 [Phase 1]
Phase 1 study evaluating the metabolic profile of OC000459 in asthma; the trial has been completed.
-
FDA approval · 2015-05-22FDA Approved: MONTELUKAST SODIUM — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' original generic application for montelukast sodium, enabling marketing of a generic montelukast pr…
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Reduction in Clinical Variance Using Targeted Design Changes in Computerized Provider Order Entry Order (CPOE) Sets [Phase 3]
This Phase 3 trial update describes targeted design changes to Computerized Provider Order Entry (CPOE) sets that reduced clinical variance …
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics [Phase 3]
Phase 3 study assessing the efficacy of inhaled albuterol Spiromax in subjects with persistent asthma; results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose) [Phase 2]
This Phase 2 trial evaluates safety, efficacy, PK, and PD of the orally inhaled SB010 in male adults with mild asthma, based on a multiple-d…
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma [Phase 3]
Phase 3 trial comparing albuterol Spiromax to placebo in adolescents and adults with persistent asthma completed; results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Improving Asthma Outcomes Through Spirometry Distance Learning [NA]
A completed clinical trial evaluated whether spirometry distance learning can improve asthma outcomes. The study was sponsored by Seattle Ch…